RXST · RxSight, Inc.

Summary

RxSight, Inc. filed an 8-K/A on March 19, 2026, to amend its January 12, 2026 Initial 8-K regarding Mark Wilterding's appointment as Chief Financial Officer, disclosing his sign-on bonus of $169,348.10 determined on March 10, 2026 and paid on March 13, 2026, and correcting the vesting schedule of his Option.

Key takeaways

• Mark Wilterding appointed CFO effective January 11, 2026 per Initial Report
• Sign-on bonus determined at $169,348.10 on March 10, 2026
• Sign-on bonus paid on March 13, 2026 less withholdings
• Option vesting: 25% on January 11, 2027, balance monthly over next 3 years
• Full Option vesting after 4 years from January 11, 2026 subject to continued employment